Skip to content

The effect of tramadol on patients with septic shock caused by generalized peritonitis

The effect of tramadol on patients with septic shock caused by generalized peritonitis - The effect of tramadol on patients with septic shock caused by generalized peritonitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000004690
Enrollment
60
Registered
2010-12-13
Start date
2010-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Tramadol 2mg/kg is administered intramuscularly after induction of anesthesia. Since then, same dose of tramadol is administered iteratively every five hours until discharge from the intensive care un

Sponsors

Japanese Red Cross Society Wakayama Medical Center Department of Anesthesiology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: After obtaining written informed consent from the patients' next of kin, ASA physical status 1 - 3 patients with generalized peritonitis who are scheduled to undergo the surgery are prospectively enrolled in this study. P1 A normal healthy patient P2 A patient with mild systemic disease P3 A patient with severe systemic disease P4 A patient with severe systemic disease that is a constant threat to life P5 A moribund patient who is not expected to survive without the operation P6 A declared brain-dead patient whose organs are being removed for donor purposes

Exclusion criteria

Exclusion criteria: 1) Age of younger than 18 years 2) Pregnancy 3) Allergy to scheduled drugs 4) Previous history of severe kidney and/or liver disease 5) Previous sulfonylurea use 6) Current use of anticonvulsant drugs 7) Inappropriate patients for study judged by the physicians

Design outcomes

Primary

MeasureTime frame
The norepinephrine requirement during and after surgery

Secondary

MeasureTime frame
Organ dysfunction score, infusion volume, urinary output, and cardiovascular drugs requirement

Countries

Japan

Contacts

Public ContactHiroshi Iranami

Japanese Red Cross Society Wakayama Medical Center Department of Anesthesiology

073-422-4171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026